Ornella Sortino1,2, Joana Dias3, Megan Anderson2, Elizabeth Laidlaw2, Edwin Leeansyah3,4, Andrea Lisco2, Virginia Sheikh2, Johan K Sandberg3, Irini Sereti2. 1. Clinical Research Directorate/Clinical Monitoring Leidos Research Program, Leidos Biomedical Research, Inc., National Cancer Institute Campus at Frederick, Frederick, Maryland, USA. 2. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. 3. Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. 4. Tsinghua-Berkeley Shenzhen Institute, Tsinghua University, Shenzhen, China.
Abstract
BACKGROUND: Mucosal-associated invariant T (MAIT) cells constitute a subset of unconventional, MR1-restricted T cells involved in antimicrobial responses as well as inflammatory, allergic, and autoimmune diseases. Chronic infection and inflammatory disorders as well as immunodeficiencies are often associated with decline and/or dysfunction of MAIT cells. METHODS: We investigated the MAIT cells in patients with idiopathic CD4+ lymphocytopenia (ICL), a syndrome characterized by consistently low CD4 T-cell counts (<300 cell/µL) in the absence of HIV infection or other known immunodeficiency, and by susceptibility to certain opportunistic infections. RESULTS: The numbers, phenotype, and function of MAIT cells in peripheral blood were preserved in ICL patients compared to healthy controls. Administration of interleukin-7 (IL-7) to ICL patients expanded the CD8+ MAIT-cell subset, with maintained responsiveness and effector functions after IL-7 treatment. CONCLUSIONS: ICL patients maintain normal levels and function of MAIT cells, preserving some antibacterial responses despite the deficiency in CD4+ T cells. CLINICAL TRIALS REGISTRATION: NCT00867269. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
BACKGROUND: Mucosal-associated invariant T (MAIT) cells constitute a subset of unconventional, MR1-restricted T cells involved in antimicrobial responses as well as inflammatory, allergic, and autoimmune diseases. Chronic infection and inflammatory disorders as well as immunodeficiencies are often associated with decline and/or dysfunction of MAIT cells. METHODS: We investigated the MAIT cells in patients with idiopathic CD4+ lymphocytopenia (ICL), a syndrome characterized by consistently low CD4 T-cell counts (<300 cell/µL) in the absence of HIV infection or other known immunodeficiency, and by susceptibility to certain opportunistic infections. RESULTS: The numbers, phenotype, and function of MAIT cells in peripheral blood were preserved in ICL patients compared to healthy controls. Administration of interleukin-7 (IL-7) to ICL patients expanded the CD8+ MAIT-cell subset, with maintained responsiveness and effector functions after IL-7 treatment. CONCLUSIONS: ICL patients maintain normal levels and function of MAIT cells, preserving some antibacterial responses despite the deficiency in CD4+ T cells. CLINICAL TRIALS REGISTRATION: NCT00867269. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Authors: Kate Buchacz; Rose K Baker; Frank J Palella; Joan S Chmiel; Kenneth A Lichtenstein; Richard M Novak; Kathleen C Wood; John T Brooks Journal: AIDS Date: 2010-06-19 Impact factor: 4.177
Authors: Hui-Fern Koay; Nicholas A Gherardin; Anselm Enders; Liyen Loh; Laura K Mackay; Catarina F Almeida; Brendan E Russ; Claudia A Nold-Petry; Marcel F Nold; Sammy Bedoui; Zhenjun Chen; Alexandra J Corbett; Sidonia B G Eckle; Bronwyn Meehan; Yves d'Udekem; Igor E Konstantinov; Martha Lappas; Ligong Liu; Chris C Goodnow; David P Fairlie; Jamie Rossjohn; Mark M Chong; Katherine Kedzierska; Stuart P Berzins; Gabrielle T Belz; James McCluskey; Adam P Uldrich; Dale I Godfrey; Daniel G Pellicci Journal: Nat Immunol Date: 2016-09-26 Impact factor: 25.606
Authors: Virginia Sheikh; Brian O Porter; Rebecca DerSimonian; Stephen B Kovacs; William L Thompson; Ainhoa Perez-Diez; Alexandra F Freeman; Gregg Roby; JoAnn Mican; Alice Pau; Adam Rupert; Joseph Adelsberger; Jeanette Higgins; Jeffrey S Bourgeois; Stig M R Jensen; David R Morcock; Peter D Burbelo; Leah Osnos; Irina Maric; Ven Natarajan; Therese Croughs; Michael D Yao; Jacob D Estes; Irini Sereti Journal: Blood Date: 2015-12-16 Impact factor: 22.113
Authors: James E Ussher; Matthew Bilton; Emma Attwod; Jonathan Shadwell; Rachel Richardson; Catherine de Lara; Elisabeth Mettke; Ayako Kurioka; Ted H Hansen; Paul Klenerman; Christian B Willberg Journal: Eur J Immunol Date: 2013-10-01 Impact factor: 5.532
Authors: Joseph C Mudd; Kathleen Busman-Sahay; Sarah R DiNapoli; Stephen Lai; Virginia Sheik; Andrea Lisco; Claire Deleage; Brian Richardson; David J Palesch; Mirko Paiardini; Mark Cameron; Irini Sereti; R Keith Reeves; Jacob D Estes; Jason M Brenchley Journal: Nat Commun Date: 2018-09-27 Impact factor: 14.919
Authors: Adam K Savage; Michael G Constantinides; Jin Han; Damien Picard; Emmanuel Martin; Bofeng Li; Olivier Lantz; Albert Bendelac Journal: Immunity Date: 2008-08-14 Impact factor: 31.745
Authors: Rangsima Reantragoon; Alexandra J Corbett; Isaac G Sakala; Nicholas A Gherardin; John B Furness; Zhenjun Chen; Sidonia B G Eckle; Adam P Uldrich; Richard W Birkinshaw; Onisha Patel; Lyudmila Kostenko; Bronwyn Meehan; Katherine Kedzierska; Ligong Liu; David P Fairlie; Ted H Hansen; Dale I Godfrey; Jamie Rossjohn; James McCluskey; Lars Kjer-Nielsen Journal: J Exp Med Date: 2013-10-07 Impact factor: 14.307